Company: CORT
Filing Date: 2025-11-04
Form Type: 8-K
Source: 0001628280-25-048814
Chunk: 1

Company: CORCEPT THERAPEUTICS INC
Filing Date: 2025-11-04
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01. Financial Statements and Exhibits

(d) Exhibits

  Exhibits No.      Description                                                                                                
          99.1      Press Release of Corcept Therapeutics Incorporated, dated No vember 4, 2025                                
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
         104.1      Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.  

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                   CORCEPT THERAPEUTICS INCORPORATED                                      
  Date:      November 4, 2025      By:                                    /s/ Atabak Mokari               
                                                                          Name: Atabak Mokari             
                                                                          Title: Chief Financial Officer